David Giarracco Email & Phone Number

Galveston, Tx, Us

Recruited by the board to fulfill the promise of Noninvasix and be the first to non-invasively monitor the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time. Our patented optoacoustic platform technology is the first solution to non-invasively and continuously measure central venous saturation. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose their critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand the use and clinical impact of our technology into other indications and settings.

Hadley, Ma, Us

ASPIRE is an intensive week-long workshop that prepares startups for the investments and partnerships necessary to launch their ventures. Mentors-in-residence works alongside startups to simulate due diligence conversations and integrate feedback into materials in real-time.

Baltimore, Maryland, Us

Advised start-up companies in developing and executing their capital fundraising, operational and commercial strategies. Clients included TissueForm, Sachi Bioworks, and Nasaclip.

Denver, Co, Us

At SeaStar Medical we recognize that critical care clinicians fight every day to save patients from the cytokine storm. This deadly threat has taken too many organs and too many lives. The severity of this threat is our call to action. We leverage our scientific expertise and resources to break past limitations of current therapies and help our heroes in critical care stop the cytokine storm and save precious lives.

The Builder Fund differentiates itself by identifying exceptional investment opportunities that are often overlooked by traditional funding organizations, by advancing the development of those opportunities. Companies selected for a Builder Fund qualify for investment and/or executive support to better position the company to receive follow-on, professional investment.

Baltimore, Maryland, Us

The successful exit of the company that was acquired by a strategic purchaser and a great return to shareholders that believed in the vision.The World's first platform to enable real-time, 3D measurements of spinal alignment intraoperatively in less than 30 seconds and with up to 80% reduction in radiation exposure compared to current X-ray solutions.

Minneapolis, Mn, Us

Established first global market development organization for Respiratory Compromise and Postoperative Neurocognitive Disorders.Drove multiple years of double-digit unit adoption and revenue growth, through multimedia awareness activities leveraging evidence and the development of novel services.Accelerated clinical evidence generation through cross-functional collaboration resulting in award winning clinical science and market expansion.Implemented a global, communication plan for clinical and economic evidence.Increased audience and awareness of evidence by strategic investments in PR and digital marketing. Demonstrated inspiration leadership resulting in employee survey result betters than benchmarks: engagement 98%, inclusion 94%, and innovation 91%; 5 consecutive quarters of growth.

Built EMS US commercial and market development organization accountable for revenue attainment.Achieved targets in FY14 and exceeded market growth of 14% in FY15, and 22% in FY16. Implemented market development function for $750M global Respiratory Compromise solutions portfolio.Established business case securing a 10 year $50M investment in Capnography to address barriers to adoption.Initiated $6.5M global post market clinical trial for demonstrating the clinical and economic impact of continuous, remote vital signs monitoring.Created Market Development Clinical Specialist organization to accelerate the technology adoption.Attained first enterprise level sale for the business by negotiating and closing $1.5M contract with a subsidiary of Capital Blue Cross.

Integrated the sales and marketing organizations of a multisite, multinational $346M Israeli acquisition with experience in restructuring the go-to-market organization.

Hired and developed an organization of product management: implemented mid- year reviews, biannual talent reviews, and marketing journal club to drive culture change organization.

Global business lead for the divestiture of Sleep and Liquid Oxygen Therapy franchises: completed three divestitures, led all aspects of contract negotiations covering US, European and Japan while demonstrating influence management over 450 Covidien employees globally.

Vice President of Marketing for the Sleep and Oxygen business.

Lead the market development activities for a $1B respiratory & monitoring solutions medical device business focused on improving global outcomes in ventilation, monitoring and home healthcare. Defined, developed and recruited the initial market development department in the organization.

Lead the global marketing efforts for a $220M world-wide franchise in electrosurgery. Major repsonsibilities included recruiting a global product management organization, identifying new product opportunities, leadership through the new product development stage gate process, and marketing program identification and implementation.

Us

Us

Us

Master Of Arts - Ma, Biomedical Engineering

Bachelor Of Science - Bs, Biomedical Engineering & Materials Science

Education record